Drug Profile
Hydrocodone/pseudoephedrine - Currax Pharmaceuticals
Alternative Names: Pseudoephedrine/hydrocodone - Currax Pharmaceuticals; REZIRALatest Information Update: 09 May 2019
Price :
$50
*
At a glance
- Originator Cypress Pharmaceutical
- Developer Currax Pharmaceuticals
- Class Antitussives; Decongestants; Morphinans; Opioid analgesics; Opioid peptides; Propanolamines; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Common cold; Cough